Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations
α-ketoglutarate is an intermediate of the Krebs Cycle that was recently reported to extend lifespan in C.Elegans. Here, the authors show that administration of α-ketoglutarate to mice reduces age-related bone loss, by ameliorating senescence of bone-marrow derived mesenchymal stem cells.
Guardado en:
Autores principales: | Yuan Wang, Peng Deng, Yuting Liu, Yunshu Wu, Yaqian Chen, Yuchen Guo, Shiwen Zhang, Xiaofei Zheng, Liyan Zhou, Weiqing Liu, Qiwen Li, Weimin Lin, Xingying Qi, Guomin Ou, Cunyu Wang, Quan Yuan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c0e3afcbf66046cca618c00251e8fdd0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Spontaneous hydrolysis and spurious metabolic properties of α-ketoglutarate esters
por: Seth J. Parker, et al.
Publicado: (2021) -
Exploring the Effect of Jiawei Buguzhi Pills on TGF-β-Smad Pathway in Postmenopausal Osteoporosis Based on Integrated Pharmacological Strategy
por: Xiao Yuan, et al.
Publicado: (2021) -
Redirected nuclear glutamate dehydrogenase supplies Tet3 with α-ketoglutarate in neurons
por: Franziska R. Traube, et al.
Publicado: (2021) -
Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis
por: Yunshu Wu, et al.
Publicado: (2018) -
Alpha-Ketoglutarate and 5-HMF: A Potential Anti-Tumoral Combination against Leukemia Cells
por: Joachim Greilberger, et al.
Publicado: (2021)